tradingkey.logo

AbbVie rises; co plans $380 mln investment in new drug ingredient plants

ReutersFeb 23, 2026 4:24 PM

Shares of drugmaker AbbVie ABBV.N rise 1.7% to $229.07

Co says it will invest $380 mln to build two new plants in North Chicago to produce ingredients for obesity and neurological drugs, using AI technologies

 Construction begins in spring 2026, with operations expected in 2029; 300 hires planned, according to co

  Co says the investment is part of its $100 bln U.S. R&D and capital spending plan; it is also acquiring a site in Arizona and expanding in Massachusetts

Shares up ~29% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI